Search

Your search keyword '"Starreveld, Daniëlle E. J."' showing total 10 results
Start Over Author "Starreveld, Daniëlle E. J."
10 results on '"Starreveld, Daniëlle E. J."'

4. Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial

Author

Starreveld, Daniëlle E. J., primary, Daniels, Laurien A., additional, Kieffer, Jacobien M., additional, Valdimarsdottir, Heiddis B., additional, de Geus, Jessie, additional, Lanfermeijer, Mirthe, additional, van Someren, Eus J. W., additional, Habers, G. Esther A., additional, Bosch, Jos A., additional, Janus, Cécile P. M., additional, van Spronsen, Dick Johan, additional, de Weijer, Roel J., additional, Marijt, Erik W. A., additional, de Jongh, Eva, additional, Zijlstra, Josée M., additional, Böhmer, Lara H., additional, Houmes, Margreet, additional, Kersten, Marie José, additional, Korse, Catharina M., additional, van Rossum, Huub H., additional, Redd, William H., additional, Lutgendorf, Susan K, additional, Ancoli-Israel, Sonia, additional, van Leeuwen, Flora E., additional, and Bleiker, Eveline M. A., additional

Published
2021
Full Text
View/download PDF

5. sj-pdf-1-jbr-10.1177_0748730420987327 – Supplemental material for Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors

Author

Starreveld, Daniëlle E. J., G. Esther A. Habers, Heiddis B. Valdimarsdottir, Kessels, Rob, Daniëls, Laurien A., Leeuwen, Flora E. Van, and Bleiker, Eveline M. A.

Subjects
FOS: Clinical medicine, FOS: Biological sciences, 110306 Endocrinology, 69999 Biological Sciences not elsewhere classified, Neuroscience
Abstract

Supplemental material, sj-pdf-1-jbr-10.1177_0748730420987327 for Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors by Daniëlle E. J. Starreveld, G. Esther A. Habers, Heiddis B. Valdimarsdottir, Rob Kessels, Laurien A. Daniëls, Flora E. van Leeuwen and Eveline M. A. Bleiker in Journal of Biological Rhythms

Published
2021
Full Text
View/download PDF

6. Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial

Author

Starreveld, Daniëlle E J, Daniels, Laurien A, Kieffer, Jacobien M, Valdimarsdottir, Heiddis B, de Geus, Jessie, Lanfermeijer, Mirthe, van Someren, Eus J W, Habers, G Esther A, Bosch, Jos A, Janus, Cécile P M, van Spronsen, Dick Johan, de Weijer, Roel J, Marijt, Erik W A, de Jongh, Eva, Zijlstra, Josée M, Böhmer, Lara H, Houmes, Margreet, Kersten, Marie José, Korse, Catharina M, van Rossum, Huub H, Redd, William H, Lutgendorf, Susan K, Ancoli-Israel, Sonia, van Leeuwen, Flora E, Bleiker, Eveline M A, Starreveld, Daniëlle E J, Daniels, Laurien A, Kieffer, Jacobien M, Valdimarsdottir, Heiddis B, de Geus, Jessie, Lanfermeijer, Mirthe, van Someren, Eus J W, Habers, G Esther A, Bosch, Jos A, Janus, Cécile P M, van Spronsen, Dick Johan, de Weijer, Roel J, Marijt, Erik W A, de Jongh, Eva, Zijlstra, Josée M, Böhmer, Lara H, Houmes, Margreet, Kersten, Marie José, Korse, Catharina M, van Rossum, Huub H, Redd, William H, Lutgendorf, Susan K, Ancoli-Israel, Sonia, van Leeuwen, Flora E, and Bleiker, Eveline M A

Abstract

PURPOSE: To evaluate the short- and long-term effects of light therapy on fatigue (primary outcome) and sleep quality, depression, anxiety, quality of life, and circadian rhythms (secondary outcomes) in survivors of (non-)Hodgkin lymphoma presenting with chronic cancer-related fatigue.METHODS: We randomly assigned 166 survivors (mean survival 13 years) to a bright white light intervention (BWL) or dim white light comparison (DWL) group. Measurements were completed at baseline (T0), post-intervention (T1), at three (T2), and nine (T3) months follow-up. A mixed-effect modeling approach was used to compare linear and non-linear effects of time between groups.RESULTS: There were no significant differences between BWL and DWL in the reduction in fatigue over time. Both BWL and DWL significantly (p < 0.001) improved fatigue levels during the intervention followed by a slight reduction in this effect during follow-up (EST0-T1 = -0.71; EST1-T3 = 0.15). Similar results were found for depression, sleep quality, and some aspects of quality of life. Light therapy had no effect on circadian rhythms.CONCLUSIONS: BWL was not superior in reducing fatigue compared to DWL in HL and DLBCL survivors. Remarkably, the total sample showed clinically relevant and persistent improvements on fatigue not commonly seen in longitudinal observational studies in these survivors.

Published
2021

7. Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors:Results of a Randomized Controlled Trial

Author

Starreveld, Daniëlle E J, Daniels, Laurien A, Kieffer, Jacobien M, Valdimarsdottir, Heiddis B, de Geus, Jessie, Lanfermeijer, Mirthe, van Someren, Eus J W, Habers, G Esther A, Bosch, Jos A, Janus, Cécile P M, van Spronsen, Dick Johan, de Weijer, Roel J, Marijt, Erik W A, de Jongh, Eva, Zijlstra, Josée M, Böhmer, Lara H, Houmes, Margreet, Kersten, Marie José, Korse, Catharina M, van Rossum, Huub H, Redd, William H, Lutgendorf, Susan K, Ancoli-Israel, Sonia, van Leeuwen, Flora E, Bleiker, Eveline M A, Starreveld, Daniëlle E J, Daniels, Laurien A, Kieffer, Jacobien M, Valdimarsdottir, Heiddis B, de Geus, Jessie, Lanfermeijer, Mirthe, van Someren, Eus J W, Habers, G Esther A, Bosch, Jos A, Janus, Cécile P M, van Spronsen, Dick Johan, de Weijer, Roel J, Marijt, Erik W A, de Jongh, Eva, Zijlstra, Josée M, Böhmer, Lara H, Houmes, Margreet, Kersten, Marie José, Korse, Catharina M, van Rossum, Huub H, Redd, William H, Lutgendorf, Susan K, Ancoli-Israel, Sonia, van Leeuwen, Flora E, and Bleiker, Eveline M A

Abstract

PURPOSE: To evaluate the short- and long-term effects of light therapy on fatigue (primary outcome) and sleep quality, depression, anxiety, quality of life, and circadian rhythms (secondary outcomes) in survivors of (non-)Hodgkin lymphoma presenting with chronic cancer-related fatigue.METHODS: We randomly assigned 166 survivors (mean survival 13 years) to a bright white light intervention (BWL) or dim white light comparison (DWL) group. Measurements were completed at baseline (T0), post-intervention (T1), at three (T2), and nine (T3) months follow-up. A mixed-effect modeling approach was used to compare linear and non-linear effects of time between groups.RESULTS: There were no significant differences between BWL and DWL in the reduction in fatigue over time. Both BWL and DWL significantly (p < 0.001) improved fatigue levels during the intervention followed by a slight reduction in this effect during follow-up (EST0-T1 = -0.71; EST1-T3 = 0.15). Similar results were found for depression, sleep quality, and some aspects of quality of life. Light therapy had no effect on circadian rhythms.CONCLUSIONS: BWL was not superior in reducing fatigue compared to DWL in HL and DLBCL survivors. Remarkably, the total sample showed clinically relevant and persistent improvements on fatigue not commonly seen in longitudinal observational studies in these survivors.

Published
2021

9. Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial

Author

Starreveld, Daniëlle E. J., primary, Daniels, Laurien A., additional, Valdimarsdottir, Heiddis B., additional, Redd, William H., additional, de Geus, Jessie L., additional, Ancoli-Israel, Sonia, additional, Lutgendorf, Susan, additional, Korse, Catharina M., additional, Kieffer, Jacobien M., additional, van Leeuwen, Flora E., additional, and Bleiker, Eveline M. A., additional

Published
2018
Full Text
View/download PDF

10. The course of fear of cancer recurrence: Different patterns by age in breast cancer survivors.

Author

Starreveld, Daniëlle E. J., Markovitz, Sabine E., van Breukelen, Gerard, and Peters, Madelon L.

Subjects
*FEAR of cancer, *BREAST cancer patients, *BREAST surgery, *CANCER relapse, *LIFE Orientation Test, *QUALITY of life, *MENTAL health, *BREAST tumors, *FEAR, *HEALTH attitudes, *REGRESSION analysis, *CANCER & psychology
Abstract

Objective: To examine the time course and predictors of fear of cancer recurrence (FCR) in breast cancer survivors over a period of 18 months after initial surgery.Methods: Breast cancer patients (n = 267) were followed until 18 months after primary breast surgery. Shortly after surgery, participants completed the Life Orientation Test-Revised to measure optimism and the Concerns about Recurrence Scale to measure FCR. Mixed regression analysis was performed with age, optimism, marital status, education, type of surgery, with or without lymphectomy, chemotherapy, hormonal therapy, or radiotherapy, time since surgery, and all interactions with time as predictors of FCR.Results: The final model included a significant interaction between age and time since surgery and a main effect for optimism.Conclusion: These results suggest that the course of FCR depends on the age of breast cancer survivors. Younger survivors showed an increase of fear during the first 1.5 years after breast surgery, whereas older survivors showed stable levels during the first 6 months after which it declined. Also, less optimistic survivors reported higher levels of FCR. Health care providers should pay (extra) attention to FCR in younger and less optimistic patients and offer psychological help when needed. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results